PharmaJet

  • Featured

    PharmaJet Announces Implementation Study Results

    PharmaJet® today announced the results of an implementation study in Nigeria that evaluated the impact on coverage, costs, and acceptability of intradermal fractional inactivated poliovirus vaccine (fIPV) administration using their Tropis® ID Needle-free System, compared to the standard of care (full-dose, IPV intramuscular delivery with needle and syringe). The study results were presented at an event attended by experts from the Nigeria…

    Read More »
Back to top button
error: Content is protected !!